antigen
loss
bind
due
point
modif
amino
acid
residu
often
consid
indic
epitop
compon
addit
comput
combinatori
method
epitop
map
also
use
method
reli
abil
antibodi
interest
affin
isol
specif
short
peptid
combinatori
phage
display
peptid
librari
peptid
regard
lead
definit
epitop
correspond
antibodi
use
screen
peptid
librari
epitop
map
comput
algorithm
develop
mapitop
recent
found
effect
map
conform
discontinu
epitop
pro
con
variou
approach
toward
epitop
map
also
discuss
without
doubt
greatest
advanc
manag
public
nate
correspond
epitop
thu
highli
potent
neutral
mab
identifi
propos
immun
health
practic
vaccin
ever
sinc
jenner
individu
epitop
mab
elicit
classic
demonstr
protect
benefit
vaccin
potent
neutral
activ
characterist
origin
mab
gloucestershir
england
score
vaccin
mab
also
highli
cross
reactiv
case
desir
develop
save
live
hundr
million
attribut
enabl
mab
bind
divers
genet
peopl
worldwid
success
vaccin
even
gone
beyond
variant
pathogen
neutral
individu
immuit
origin
object
empow
individu
immun
nize
mab
epitop
would
also
acquir
abil
variou
pathogen
today
appear
broadli
cross
neutral
diverg
pathogen
thu
crux
persist
vaccin
diseas
erad
problem
revers
immunolog
approach
face
earth
common
implement
abl
backtrack
mab
desir
activ
correspondvaccin
expos
vaccine
kill
intact
ing
epitop
step
develop
epitopebas
pathogen
one
attenu
either
case
vaccin
subject
review
need
cultur
pathogen
high
quantiti
effect
inactiv
ultim
subject
vaccine
full
spectrum
advantag
epitopebas
vaccin
pathogen
antigen
complex
howev
year
becom
clear
antigen
provid
although
exampl
commerci
avail
epitopedegre
protect
fact
case
may
base
vaccin
current
exist
nonetheless
believ
disadvantag
rais
immun
respons
specif
aspect
type
vaccin
intrins
advantag
realiz
pathogen
case
induc
autoimmun
due
futur
list
discuss
section
pathogen
mimicri
nativ
antigen
therefor
advent
recombin
dna
technolog
new
concept
focus
immun
respons
nation
emerg
isol
antigen
replac
intact
pathogen
natur
pathogen
plethora
antigen
vaccin
obvious
afford
abil
focu
compris
ten
hundr
potenti
epitop
certainli
immun
respons
effect
target
also
benefit
antigen
epitop
equal
use
gener
protect
advantag
manufactur
recombin
protein
oppos
immun
also
assum
individu
mount
cultur
infecti
agent
process
strong
hightit
respons
potenti
epitop
fact
safeti
inde
vaccin
base
isol
antigen
refer
complex
antibodi
individu
polyclon
serum
subunit
vaccin
becom
effect
use
ever
correspond
rel
limit
collect
epitop
may
expand
necessarili
includ
import
protectak
reductionist
approach
one
step
one
tion
thu
creat
cocktail
defin
epitop
select
propos
use
select
isol
epitop
vaccin
modalitheir
abil
afford
proven
protect
one
abl
tie
effect
subunit
vaccin
identifi
one
focu
immun
system
gener
prefer
repertoir
might
abl
gain
advantag
identifi
specif
antibodi
hand
pick
job
epitop
provid
protect
produc
individu
use
isol
epitop
immunogen
conceptu
enhanc
immun
simplest
way
identifi
desir
epitop
isol
monoclon
antibodi
mab
bind
one
would
expect
within
divers
antigen
epitop
pathogen
mab
repres
ultim
desir
effect
vaccinot
equal
abil
elicit
antibodi
product
often
find
epitop
seem
domin
gen
enhanc
antibodi
propos
strong
respons
toward
may
expens
abl
mean
infect
via
altern
rout
via
back
door
respond
epitop
pathogen
one
thing
propos
mechan
might
explain
certain
domin
epitop
necessarili
independ
infect
epitopebas
vaccin
correspond
effect
neutral
one
fact
natur
could
design
reduc
amount
ineffect
antibodi
select
pressur
tend
drive
occlus
neutral
infect
individu
thu
increas
specif
activ
epitop
pathogen
pathogen
gain
select
advanneutr
antibodi
tage
abl
obscur
weak
point
distract
second
danger
mount
antibodi
pathogen
host
immun
system
devis
seduct
epitop
littl
stem
possibl
epitop
mimet
nativ
host
protect
valu
achiev
creat
bait
sort
protein
develop
autoimmun
connect
particularli
surfaceaccess
hydrophil
yet
amewith
viral
infect
idea
event
nabl
constant
genet
variat
exampl
five
variabl
foreign
antigen
structur
similar
nativ
host
proloop
highli
immunogen
tein
mount
antibodi
toward
similar
structur
may
ever
chang
natur
allow
swarm
hiv
evad
lead
crossreact
bind
antibodi
autoimmun
surveil
constantli
mutat
bind
antigen
lead
patholog
autoimmun
note
capac
antibodi
produc
first
encount
case
crossreact
detriment
compar
desir
epitopebas
vaccin
would
contribut
overcom
effect
describ
previous
case
point
recent
problem
envisag
epitop
would
select
describ
vaccin
develop
borrelia
burgdorferi
abil
elicit
potent
neutral
rather
natur
sur
agent
caus
lyme
diseas
outer
surfac
protein
face
access
epitop
like
correspond
ospa
bacterium
contain
short
sequenc
nine
amino
conserv
aspect
pathogen
toler
modificaacid
homolog
human
leukocyt
function
tion
natur
select
evolv
less
immunoassoci
result
lyme
vaccin
genic
exampl
aspect
must
base
recombin
ospa
postul
induc
function
receptor
recognit
requir
correspond
autoimmun
reaction
autoantigen
result
arthrit
invari
structur
host
eg
symptom
target
delet
nonapeptid
epitop
epitop
buri
result
comparaospa
propos
solut
problem
tive
less
immunogen
lead
product
rel
obvious
develop
epitopebas
vaccin
one
would
antibodi
natur
progress
disabl
ration
design
epitop
cocktail
exclud
epitop
eas
isol
epitop
present
could
associ
autoantigen
context
ie
immun
absenc
rest
reduc
cost
viru
one
gain
desir
effect
enhanc
immunogen
produc
epitopebas
vaccin
deriv
product
vaccin
technic
complic
conserv
aspect
viral
antigen
would
biohazard
manufactur
requir
cultur
larg
promis
focus
hope
function
protect
volum
pathogen
moreov
pathogen
may
immun
also
effici
immun
respons
toward
idiosyncrasi
translat
develop
custom
taithem
lore
protocol
product
requir
specif
condit
reagent
assum
effect
epitopebas
vaccin
availa
ble
product
perceiv
less
complic
much
safer
certainli
cheaper
long
run
gener
antibodi
respons
infect
alway
advantag
wherea
intent
immun
respons
three
step
epitopebas
vaccin
product
neutral
pathogen
ultim
consequ
antibodi
produc
anticip
immun
system
discuss
first
step
develop
epitopethu
deleteri
effect
might
also
occur
base
vaccin
identifi
epitop
obvious
two
type
undesir
effect
recogn
epitop
correspond
ultim
immun
respons
defirst
situat
gener
antibodi
noneffect
sire
ie
broad
cross
neutral
bcn
genet
epitop
exampl
lead
infect
macrophag
due
divers
pathogen
protect
requir
disfcreceptormedi
endocytosi
immunocomplex
pathocoveri
epitop
could
serendipit
experiment
trial
error
howev
ration
design
step
monoclon
antibodyguid
map
bcell
epitop
cine
would
prefer
concept
backtrack
mab
proven
bcn
activ
seem
effici
mean
singl
epitop
candid
vaccin
product
epitop
defin
second
step
would
reconstitut
epitop
function
immunogen
given
target
mab
exist
task
us
map
number
consider
must
taken
account
correspond
epitop
within
antigen
bind
simplest
first
bcell
epitop
oppos
tcell
epitop
often
case
major
element
epitop
may
linear
segment
antigen
isol
form
continu
bind
mab
discontinu
highli
conform
fact
even
detect
affin
discoveri
segment
accomplish
event
signific
portion
epitop
short
linear
screen
mab
geysen
pepscan
mario
peptid
promis
peptid
repres
geysen
introduc
idea
gener
seri
overlap
entir
epitop
requir
distinct
conform
linear
peptid
cover
entireti
antigen
studw
recogn
even
short
linear
peptid
greatli
depend
i
case
array
peptid
react
three
dimension
conform
bioactiv
thu
antibodi
segment
continu
bind
repres
exampl
presum
short
peptid
hormon
signific
aspect
epitop
linear
peptid
neurotransmitt
leuor
metenkephalin
residu
test
capac
elicit
desir
effect
use
angiotensin
ii
residu
substanc
p
residu
peptid
immunogen
pepscan
also
indic
compoexempt
specif
conform
requir
physin
discontinu
epitop
event
two
distant
olog
function
peptid
contain
suffici
structur
element
allow
bcell
epitop
typic
compris
residu
dethem
bind
mab
separ
one
would
conclud
rive
discontinu
segment
antigen
brought
two
peptid
contribut
intact
epitop
type
togeth
fold
produc
contigu
surfac
analys
requir
solv
atom
structur
recogn
antibodi
task
reconstitut
effecth
antigen
tive
epitopebas
vaccin
must
take
fact
consider
recent
year
classic
pepscan
incorpor
attempt
posit
critic
contact
residu
proper
microarray
applic
exampl
see
cretich
et
al
spatial
orient
mean
easi
task
final
poetz
et
al
use
high
throughput
system
well
reconstitut
epitop
could
either
base
actual
antigen
multiplex
segment
tack
onto
support
scaffold
sort
altern
may
function
similar
epitop
struc
tural
unrel
mimet
instanc
presum
bcell
epitop
simpl
linear
sequenc
rather
function
moieti
epitop
effect
situat
space
highli
conform
discontinu
structur
therefor
use
altern
residu
chemistri
recreat
landscap
rare
compat
pepscan
analys
similar
epitop
use
composit
final
simpler
yet
less
comprehens
approach
would
attempt
reconstitut
partial
structur
element
gold
standard
epitop
definit
becom
coepitop
exampl
epitop
compris
seri
anticrystal
antigen
antibodi
complex
follow
soluparallel
strand
form
number
juxtapos
hairpin
one
tion
atom
structur
use
xray
diffract
analysi
might
consid
attempt
reconstruct
hairpin
separ
system
highli
purifi
antigen
correspond
antibodi
instead
tri
encompass
epitop
entireti
allow
cocrystal
form
antigen
antibodi
complex
mimet
reconstitut
epitop
produc
third
crystal
interrog
xray
due
highli
step
develop
epitopebas
vaccin
would
structur
repeat
natur
crystal
unit
diffract
pattern
produc
effect
immunogen
epitop
would
need
gener
relat
fourier
transform
mount
onto
carrier
scaffold
one
would
conto
coordin
electron
densiti
front
task
develop
effect
immunizaamino
acid
compos
antigen
bound
antibodi
tion
scheme
consid
rout
immun
adjuv
epitop
essenc
antigen
compon
antigen
animmun
schedul
tibodi
interfac
wherea
epitop
character
deriv
xray
crystallographi
spectacular
method
highli
sophistiresidu
show
absolut
enhanc
nmr
analys
cate
tediou
demand
rather
caprici
argu
form
contact
ie
close
proxim
fab
thu
two
biophys
method
excel
hundr
thousand
antibodi
delin
boundari
antigen
antibodi
interfac
produc
year
uniqu
cocryst
definit
residu
actual
contribut
bind
gener
solv
illustr
except
low
overand
degre
may
still
matter
controversi
effici
techniqu
nonetheless
cocryst
obtain
one
assum
atom
structur
faith
repres
genuin
structur
antigen
antibodi
comput
dock
rel
orient
respect
one
anoth
defin
precis
interfac
ie
surfac
less
demand
cocrystal
product
two
epitop
design
actual
contact
residu
separ
crystal
structur
one
antigen
matter
interpret
antibodi
satisfact
prerequisit
open
option
comput
dock
mean
epitop
discoveri
gener
al
abund
structur
isol
antibodi
second
biophys
approach
toward
epitop
map
use
fab
product
new
structur
either
experiment
nuclear
magnet
reson
nmr
contrast
crystallograor
comput
model
becom
reason
effici
thu
phi
nmr
give
dynam
pictur
antigen
antibodi
comin
event
structur
obtain
antigen
plex
solut
structur
complex
result
question
gener
model
specif
correspond
anatom
definit
antigen
antibodi
interfac
deriv
tibodi
pose
problem
two
structur
exist
measur
effect
magnet
field
puls
electromagnetsepar
batteri
comput
algorithm
exist
use
ic
radiat
proton
protein
complex
attempt
dock
silico
one
structur
onto
structur
deriv
specif
manner
ultim
goal
dock
algorithm
determin
structh
proton
associ
amino
acid
absorb
electromagnettur
complex
separ
determin
coordin
ic
radiat
sampl
subject
high
magnet
field
compon
kuntz
colleagu
came
modul
absorb
spectrum
residu
caus
first
wide
use
dock
program
name
dock
sinc
neighbor
residu
intens
effect
correth
dock
field
flourish
mani
new
algorithm
late
distanc
residu
neighbor
thu
dock
predict
base
assumpt
measur
distanc
angl
restraint
structur
complex
repres
lowest
free
energi
state
model
protein
gener
access
system
often
achiev
geometth
major
limit
method
asid
high
degre
rical
complementar
dock
algorithm
differ
sophist
demand
technic
expertis
expens
method
use
gener
candid
solut
instrument
typic
restrict
rel
small
score
function
appli
evalu
search
method
protein
kda
nonetheless
nmr
use
studi
classifi
three
categori
bruteforc
local
featur
bind
epitop
fragment
fab
one
learn
much
algorithm
nondeterminist
method
panel
natur
epitop
recognit
possibl
solut
gener
candid
solut
score
gener
compar
structur
obtain
crystallografrom
least
like
like
repres
genuin
phi
versu
nmr
one
conclud
two
method
complecomplex
score
function
take
account
one
ment
well
gener
similar
structur
alfeatur
shape
complementar
contact
area
hydrogen
though
differ
detail
exist
case
point
bind
bond
electrostat
interact
salvat
energi
etc
carbohydratemimet
peptid
mdwnmhaa
dock
predict
complet
two
question
anticarbohydr
antibodi
direct
oformul
given
cours
experiment
coordin
polysaccharid
shigella
flexneri
nmr
analys
would
genuin
complex
avail
rank
number
indic
proton
ppm
solut
closest
bona
fide
complex
qualiti
residu
clearli
contact
antibodi
howev
supof
solut
close
compar
genuin
port
crystal
structur
methyl
group
situat
interfac
away
residu
antibodi
although
consider
improv
achiev
hand
crystal
structur
strongli
suggest
design
score
function
still
weakest
compon
dock
residu
clear
contact
residu
yet
two
algorithm
even
nearn
complex
found
sion
protein
abl
local
ligand
bind
site
necessarili
rank
one
top
score
solut
segment
subunit
receptor
contain
amino
acid
residu
principl
long
one
gener
fragment
dock
procedur
success
small
molecul
continu
bind
one
attempt
identifi
smallest
dock
exampl
predict
enzymeinhibitorligand
comseg
receptor
antigen
continu
recogn
plex
gener
rel
accur
result
case
thu
bind
per
se
serv
extrem
effect
monitor
small
molecul
rigid
correspond
bind
site
well
presenc
function
aspect
epitop
exploit
structur
pocket
close
follow
contour
ligand
oper
definit
epitop
segment
continu
neg
relief
complement
physicochem
requirebind
antibodi
number
experiment
strategi
ment
electrostat
charg
complement
neg
employ
map
epitop
posit
charg
antibodyhapten
complex
also
reproduc
success
exampl
phosphocholin
bind
mutagenesi
immunoglobulin
steroid
bind
antibodi
target
molecul
rigid
allow
one
simplest
popular
approach
toward
one
introduc
flexibl
antibodi
bind
site
without
epitop
map
regard
technic
implement
site
gener
infinit
number
solut
flexibl
direct
mutagenesi
concept
straightforward
one
bind
site
help
predict
conform
rearrang
replac
amino
acid
given
posit
antigen
occur
antibodi
recognit
anoth
test
bind
capac
modifi
protein
compar
small
molecul
dock
protein
protein
interloss
bind
taken
indic
modifi
residu
could
face
rel
larg
partner
flexibl
tend
associ
epitop
question
gener
two
apundergo
conform
chang
make
dock
extrem
proach
possibl
alanin
scan
mutagenesi
asm
difficult
fact
accur
result
best
obtain
satur
mutagenesi
start
point
two
alreadi
cocrystal
protein
structur
often
call
bound
dock
howev
unbound
dock
applic
involv
structur
separ
crystal
proasm
alanin
walk
systemat
approach
tein
also
call
predict
dock
yield
mani
falseposit
mutagenesi
one
introduc
alanin
everi
residu
solut
theoret
good
surfac
complementar
given
sequenc
one
time
posit
contain
alanin
score
extrem
high
actual
total
origin
sequenc
usual
replac
glycin
thu
irrelev
nativ
complex
therefor
appear
suspect
stretch
antigen
analyz
hope
wherea
comput
dock
method
extrem
attract
identifi
specif
residu
critic
mab
recognit
conceptu
case
antibodyantigen
dock
result
asm
provid
import
inform
proteinbind
interfor
moment
less
satisfi
face
method
labori
mani
mutant
must
produc
purifi
evalu
regard
structur
integr
bind
constant
mutant
furthermor
asm
experi
ment
interpret
result
confus
often
correspond
well
physic
bind
site
defin
number
method
epitop
character
reli
crystallograph
studi
function
bind
mab
antigen
deriv
one
approach
limit
scope
problem
epitop
map
case
point
analysi
sever
acut
respiratori
test
abil
antibodi
continu
bind
syndrom
sar
coronaviru
spike
glycoprotein
receptor
bindfrag
antigen
thu
bind
assay
elisa
dot
ing
domain
rbd
complex
receptor
angiotensin
conblot
western
blot
assay
provid
insight
locat
vert
enzym
ii
residu
rbd
epitop
within
gross
anatomi
antigen
subject
asm
six
found
compoexampl
epitop
mab
nent
actual
bind
surfac
ultim
determin
coloc
first
residu
cleavag
antigen
crystal
total
exchang
inde
fragment
express
truncat
version
antigen
dramat
effect
rbd
bind
surprisingli
howev
illustr
first
domain
antigen
bind
three
actual
contact
residu
antibodi
similarli
systemat
biochem
analys
enzyment
thu
modif
three
residu
matic
degrad
subunit
nicotin
acetylcholin
bind
site
impact
bind
moreov
receptor
use
synthet
peptid
express
furemain
eight
mutat
profound
inhibitori
effect
bind
fact
situat
outsid
boundari
altern
asm
satur
mutagenesi
bind
surfac
goe
illustr
mutat
residu
less
systemat
approach
introduc
singl
residu
modificaoutsid
bona
fide
epitop
result
loss
bind
possibl
tion
technic
number
method
use
impli
import
structur
integr
functo
randomli
insert
mutat
throughout
sequenc
antit
epitop
rather
role
contact
residu
per
se
gen
one
method
product
peptid
limit
structur
inform
avail
residu
would
number
mutat
per
molecul
bias
random
mistakenli
assign
bind
epitop
altern
mutagenesi
techniqu
correspond
oligonucleoth
case
sar
interfac
mutat
bona
fide
tide
synthes
use
phosphoramidit
monom
precursor
contact
residu
alanin
necessarili
interfer
contamin
regul
amount
three
nucleotid
bind
precursor
degre
contamin
phosphoramidit
need
anoth
exampl
antihel
hen
eggwhit
lysozym
achiev
desir
mutat
frequenc
per
peptid
antibodi
hel
interfac
turn
highli
calcul
use
algorithm
describ
ophir
gershoni
toler
mutat
alanin
mutat
contact
random
mutat
also
achiev
use
chemic
reagent
sodium
bisulfit
hydroxylamin
nitrou
acid
residu
determin
cocryst
hel
significantli
reagent
induc
structur
modif
specif
base
reduc
antibodi
bind
altern
mutat
critic
conth
dna
sequenc
result
altern
base
pair
tact
residu
ala
result
loss
one
hydrogen
thu
chang
dna
sequenc
addit
chemic
bond
seven
van
der
waal
contact
antibodi
reagent
formic
acid
hydrazin
capabl
impact
bind
explain
fact
damag
dna
base
thu
prevent
watsoncrick
pair
three
water
molecul
fill
void
creat
substitut
ultim
caus
misincorpor
nucleotid
ala
therefor
compens
lack
prone
polymeras
chain
reaction
pcr
wide
use
function
asp
moieti
allow
bind
activ
persist
mutagenesi
techniqu
implement
use
lowfidel
indic
mani
residu
compris
dna
polymeras
effici
introduc
random
mutat
epitop
absolut
critic
interact
provid
essenti
along
amplifi
sequenc
contact
requir
antibodi
recognit
result
absenc
cocryst
contact
residu
toler
muta
tion
would
includ
predict
epitop
whatev
method
ultim
goal
randomli
cover
mutat
also
direct
target
fashion
surfac
antigen
mutat
score
mab
bind
name
base
assumpt
potenti
involv
inhibit
bind
taken
indic
role
given
residu
area
antigen
mab
bind
one
origin
residu
mutat
antibodi
recognit
thu
epitop
map
stem
identif
cluster
systemat
construct
mutat
specif
test
effect
mutat
strongli
affect
mab
bind
alter
select
residu
exampl
order
local
problem
mutat
contact
residu
alway
result
fab
epitop
residu
loss
mab
bind
moreov
loss
bind
often
select
alanin
exchang
mutagenesi
direct
result
modif
residu
lie
outsid
epitop
structur
inform
epitop
recogn
compet
instanc
degre
success
random
mutagenesi
antibodi
mutant
construct
eight
result
signific
mean
predict
epitop
determin
studi
reduct
antibodi
bind
subsequ
crystal
crystal
structur
histidin
phosphocarri
protein
hpr
structur
solv
becam
appar
mab
complex
among
random
mutat
made
substitut
made
residu
fell
within
surfac
hpr
contact
residu
defin
cogenuin
bind
epitop
nonetheless
six
alanin
mutacryst
thirteen
mutat
result
reduct
tion
four
effect
bind
predict
mab
bind
nine
residu
lay
within
genuin
part
epitop
wherea
two
mutat
impair
bind
bind
epitop
howev
remain
four
inhibitori
mutat
significantli
moreov
six
mutat
outsid
epitop
residu
total
remov
bind
interfac
signific
effect
antibodi
bind
furthermor
mutat
three
bona
fide
contact
residu
realiz
major
mutat
affect
bind
virtual
effect
bind
indic
actual
part
genuin
epitop
substitut
epitoperesidu
often
accommod
summari
target
random
mutagenesi
easili
perpurifi
phage
correspond
linear
stretch
antigen
form
method
often
gener
dramat
effect
mab
epitop
map
becom
self
evid
howev
gener
one
bind
mutat
antigen
howev
view
fact
obtain
collect
phage
necessarili
resembl
mutat
contact
residu
either
inhibit
bind
enhanc
bindantigen
situat
one
assum
phage
ing
effect
interpret
mutagenesi
specif
bind
mab
reflect
epitop
fashion
experi
confus
residu
outsid
area
epitop
also
impact
mab
bind
question
becom
extract
panel
mab
thu
epitop
predict
mutagenesi
best
considbind
peptid
inform
pertain
nativ
epitop
ere
caution
sought
basic
two
approach
first
empir
repeat
round
biopan
one
select
peptid
bind
antibodi
contrast
biophys
biochemicalimmunobind
effici
irrespect
fact
may
homoloapproach
analys
stem
examin
precis
gou
segment
linear
sequenc
antigen
structuresequ
antigen
question
total
differ
best
bind
peptid
consid
peptidomimet
concept
also
proven
effect
epitop
map
epitop
although
differ
composit
strucidea
test
bind
capac
vast
collect
random
ture
compar
genuin
epitop
abl
mimic
peptid
repres
huge
divers
possibl
combin
latter
function
thu
mimet
view
amino
acid
sequenc
smith
petrenko
illustr
abl
place
critic
contact
moieti
spatial
defin
posion
exploit
phage
display
system
purpos
tion
correspond
similar
structur
epitop
short
peptid
express
surfac
filament
situat
best
bind
mimet
consid
potenti
bacteriophag
surrog
genuin
epitop
use
immu
nogen
hope
elicit
antibodi
favor
phage
display
librari
random
peptid
construct
cross
react
origin
antigen
success
use
phage
display
vector
short
oligonucleotid
eg
report
approach
base
correspond
six
codon
creat
hexapeptid
second
applic
random
peptid
librari
actualclon
end
either
protein
protein
gene
ly
regard
affin
purifi
panel
mab
bind
peptid
phage
random
natur
produc
allow
posit
dataset
use
epitop
map
within
atom
oligonucleotid
assum
four
base
gatc
structur
antigen
also
two
approach
manner
possibl
combin
base
consequ
describ
first
one
seek
align
peptid
area
amino
acid
express
phage
thu
display
structur
antigen
thu
take
peptid
code
singl
strand
genom
sequenc
given
peptid
one
tri
match
residu
physic
linkag
peptid
genet
code
allow
residu
surfac
antigen
irrespect
linear
one
affin
isol
phage
bind
mab
interest
connect
number
algorithm
develop
elucid
sequenc
peptid
standard
dna
sequencdo
automat
basi
peptid
ing
signific
fragment
thereof
regard
unit
inforov
year
numer
phage
display
peptid
librari
mation
contrast
approach
altern
computabeen
produc
use
extens
character
bcell
tional
predict
algorithm
develop
epitop
gener
procedur
straightforward
panel
peptid
analyz
collect
mab
analyz
immobil
solid
surfac
react
mapitop
algorithm
comprehens
librari
random
peptid
usual
mapitop
novel
comput
algorithm
predict
order
differ
peptid
typic
residiscontinu
bcell
epitop
base
notion
panel
due
long
may
may
disulfid
constrain
peptid
deriv
random
peptid
librari
collect
repreprocess
coin
biopan
result
sent
epitop
mab
bind
random
peptid
resembl
mab
epitop
manner
bound
immobil
mab
other
wash
underli
principl
mapitop
simplest
away
affin
bound
phage
collect
meaning
fragment
epitop
amino
acid
pair
aap
peptid
sequenc
determin
sequenc
affin
residu
lie
within
footprint
epitop
aap
phage
contain
insert
use
neg
control
signal
produc
use
enhanc
chemiluminesc
bublil
et
al
permiss
relat
one
anoth
surfac
antigen
exampl
peptid
sequenc
would
written
cluster
pair
defin
constitut
major
seri
pair
ab
bc
cd
de
etc
aap
deriv
epitop
footprint
ie
predict
epitop
essenc
cluster
panel
peptid
pool
frequenc
type
connect
aap
aap
epitop
need
consecucalcul
determin
whether
represent
pool
tive
tandem
residu
antigen
often
result
higher
random
expect
base
theoret
amino
juxtaposit
distant
residu
brought
togeth
fold
acid
frequenc
phage
librari
signific
aap
polypeptid
chain
aap
epitop
simul
consid
statist
signific
pair
ssp
thu
tandem
residu
peptid
affin
select
random
peptid
assum
contain
one
epitoperelev
aap
librari
basi
mab
recognit
peptid
order
identifi
meaning
aap
present
figur
demonstr
fundament
concept
alpanel
peptid
peptid
deconvolut
pair
gorithm
role
ssp
mab
recognit
note
fig
spacefil
represent
mapitop
predict
monoclon
antibodi
epitop
surfac
antigen
b
trastuzumab
epitop
surfac
receptor
number
amino
acid
compris
antigen
surfac
genuin
predict
epitop
given
also
given
number
correctli
predict
residu
indic
green
overpredict
residu
indic
red
residu
miss
indic
blue
pvalu
express
hypergeometr
distribut
probabl
randomli
predict
epitop
calcul
describ
mayros
et
al
